Pharmaceuticals 16 (12), 1674
Ebben az rsban a sokak ltal mr legalbb hrbl ismert fogyaszt injekcik, a GLP-1 gygyszerek hasznlatnak gyakorlati krdseit jrom krbe
Neuroprotection: Protects against ischemic stroke and CNS damage via the gutbrain axis (PMC8504390)
These preclinical insights have been validated in large-scale clinical trials.The FLOW trial (n = 3,533) showed that once-weekly subcutaneous administration of semaglutide (1.0 mg) significantly reduced the risk of a renal composite endpointincluding 50% decline in eGFR, renal failure, or cardiovascular deathby 24% in patients with T2DM and chronic kidney disease (CKD) (HR = 0.76, 95% CI: 0.660.88
Clinical trial data from semaglutide studies report dizziness in 58% of participants, usually occurring during dose escalation or in users with rapid blood glucose reduction
Its nearly certain that every scenario we sketch out here will come true at some scale, but its the scale of the bigger picture thats important to keep in mind
